Variant position: 1696 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 2871 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human PDYMQVNGGNNCMDMRRSLC YRNYYADNQTCDGELLFNMTK
Mouse PDYMQVNGGNNCMDMRRSLC YRNYYADNQTCDGELLFNMTK
Pig PDYMQVNGGNNCMDMRRSLC YRNYYADNQTCDGELLFNMTK
Bovine PDYMQVNGGNNCMDMRRSLC YRNYYADNQTCDGELLFNMTK
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Mutations in the TGFbeta binding-protein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias.
Le Goff C.; Mahaut C.; Wang L.W.; Allali S.; Abhyankar A.; Jensen S.; Zylberberg L.; Collod-Beroud G.; Bonnet D.; Alanay Y.; Brady A.F.; Cordier M.P.; Devriendt K.; Genevieve D.; Kiper P.O.; Kitoh H.; Krakow D.; Lynch S.A.; Le Merrer M.; Megarbane A.; Mortier G.; Odent S.; Polak M.; Rohrbach M.; Sillence D.; Stolte-Dijkstra I.; Superti-Furga A.; Rimoin D.L.; Topouchian V.; Unger S.; Zabel B.; Bole-Feysot C.; Nitschke P.; Handford P.; Casanova J.L.; Boileau C.; Apte S.S.; Munnich A.; Cormier-Daire V.;
Am. J. Hum. Genet. 89:7-14(2011)
Cited for: VARIANTS GPHYSD2 CYS-1696; ASP-1699; CYS-1699; TYR-1706; TRP-1719; THR-1728; VAL-1728; TYR-1733 AND SER-1762; VARIANTS ACMICD CYS-1699; CYS-1700; ARG-1714; CYS-1722; VAL-1726; THR-1728; GLN-1735 INS; ARG-1750 AND VAL-1758;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.